GP-100 antigen Completed Phase 3 Trials for Stage IV Melanoma / Stage IIIB Skin Melanoma / Recurrent Melanoma / Stage IIIA Skin Melanoma / Stage IIIC Skin Melanoma Treatment

Indications	Status	Purpose	Phase
DBCOND0028660 (Stage IV Melanoma) DBCOND0029534 (Stage IIIB Skin Melanoma) DBCOND0028662 (Recurrent Melanoma) DBCOND0029533 (Stage IIIA Skin Melanoma) DBCOND0029535 (Stage IIIC Skin Melanoma)	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT00019682	Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma	Aldesleukin (DB00041) GP-100 antigen (DB14800) Incomplete Freund's adjuvant (DB17475) Teceleukin (DB15389)